Valuation: Sysmex Corporation

Market Cap 1,189B 7.56B 6.75B 6.23B 5.66B 10.62B 717B 10.78B 75.04B 29.56B 375B 28.39B 27.79B P/E 2027 *
29.7x
P/E 2028 * 24.2x
Enterprise Value 1,210B 7.7B 6.87B 6.34B 5.76B 10.81B 729B 10.97B 76.37B 30.08B 382B 28.9B 28.28B EV / Sales 2027 *
2.21x
EV / Sales 2028 * 2.09x
Free-Float
71.34%
Yield 2027 *
2.05%
Yield 2028 * 2.14%
1 day+0.89%
1 week+7.76%
Current month+7.11%
1 month+5.75%
3 months+32.00%
6 months+42.69%
Current year+28.21%
1 week 11.35
Extreme 11.35
13.01
1 month 11.15
Extreme 11.15
13.01
Current year 8.01
Extreme 8.01
13.01
1 year 8.01
Extreme 8.01
13.01
3 years 8.01
Extreme 8.01
22
5 years 8.01
Extreme 8.01
46.27
10 years 8.01
Extreme 8.01
46.27
Manager TitleAgeSince
Chief Executive Officer 77 2018-03-31
Director of Finance/CFO 56 -
President 65 2026-03-31
Director TitleAgeSince
Chairman 77 2013-03-31
Director/Board Member 65 2019-05-31
Director/Board Member 71 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.89%+7.76% - - 7.51B
+1.56%-2.24%-20.02%+6.84% 174B
+3.02%+4.91%-20.78%+16.72% 114B
+2.79%+0.37%-0.10%+32.34% 114B
+1.93%+19.13%-43.11%+7.04% 89.64B
-0.15%-0.17%+3.03%+80.50% 64.96B
-0.47%+3.86%+15.10%+80.50% 56.09B
+1.66%+2.52%+5.60%-22.38% 52.94B
+2.16%+3.66%-10.51%+32.61% 43.6B
+3.43%+4.93%-5.06%-10.80% 32.77B
Average +1.70%+4.44%-8.43%+24.82% 82.44B
Weighted average by Cap. +1.85%+3.58%-12.15%+22.97%

Financials

2027 *2028 *
Net sales 549B 3.49B 3.11B 2.87B 2.61B 4.9B 331B 4.97B 34.62B 13.64B 173B 13.1B 12.82B 577B 3.67B 3.28B 3.02B 2.75B 5.16B 348B 5.23B 36.44B 14.35B 182B 13.79B 13.49B
Net income 40.33B 257M 229M 211M 192M 360M 24.3B 366M 2.54B 1B 12.73B 963M 942M 49.41B 314M 281M 259M 235M 441M 29.77B 448M 3.12B 1.23B 15.6B 1.18B 1.15B
Net Debt 21.13B 134M 120M 111M 101M 189M 12.73B 192M 1.33B 525M 6.67B 505M 494M 20.46B 130M 116M 107M 97.34M 183M 12.32B 185M 1.29B 508M 6.46B 488M 478M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
26-10-22 US$12.50 +0.89% 228,223
26-10-21 US$12.39 +4.82% 21,632
26-10-20 US$11.82 +2.80% 1,192,007
26-10-19 US$11.50 -1.47% 960,766
26-10-16 US$11.67 +0.60% 1,500,117
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,960.50JPY
Average target price
2,139.29JPY
Spread / Average Target
+9.12%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sysmex Corporation